MSS/ MMRp
Quiénes somos
Phase 2 Study of SR-8541A in Combination With Botensilimab and Balstilimab in Subjects With Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC)
A Study of AK112 With or Without AK117 in Metastatic Colorectal Cancer
A Dose Escalation Study of AV-380 in Metastatic Cancer Patients With Cachexia
A Phase I Clinical Study of Intratumoral Injection Oncolytic Vaccinia Virus GC001 in Patient With Advanced Solid Tumors
HRYZ-T102 TCR-T Cell for AFP Positive Advanced HCC and Other Solid Tumors
Autologous T-cells Genetically Engineered to Express Receptors Reactive Against KRAS Mutations in Conjunction With a Vaccine Directed Against These Antigens in Participants With Metastatic Cancer
Anti-CEACAM5 ADC M9140 in Advanced Solid Tumors (PROCEADE-CRC-01)
Low and Intermediate Risk oliGometastatic coloREctal cancEr patieNts Treated With Stereotactic ABlative Radiotherapy
Plataforma de estudio de combinaciones de inmunoterapia en metástasis hepáticas de cáncer colorrectal
MSLN-targeted CAR-T Cells in Solid Tumors.
